See accompanying notes to the unaudited condensed
consolidated financial statements
See accompanying notes to the unaudited condensed
consolidated financial statements
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 1 – NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING
POLICIES
Nature
of Business
Kush
Bottles, Inc. (“the Company”) was incorporated in the state of Nevada on February 26, 2014. The Company specializes
in the wholesale distribution of packaging supplies for the cannabis industry. The Company’s wholly owned subsidiary Kim
International Corporation (KIM), a California corporation, was originally incorporated as Hy Gro Economics Corporation ("Hy
Gro") on December 2, 2010. On October 30, 2012, Hy Gro amended its articles of incorporation to reflect a name change to KIM
International Corporation (KIM). On March 4, 2014, the shareholders of KIM exchanged all 10,000 of their common shares for 32,400,000
common shares of Kush Bottles, Inc. The operations of KIM became the operations of Kush after the share exchange and accordingly
the transaction is accounted for as a recapitalization of KIM whereby the historical financial statements of KIM are presented
as the historical financial statements of the combined entity. KIM was the acquiring entity in accordance with ASC 805, Business
Combinations. The accumulated losses of KIM were carried forward after the completion of the share exchange. Operations prior to
the share exchange were those of KIM.
Acquisition
of CMP Wellness, LLC
On May
1, 2017, the Company entered into an agreement of merger agreement with Lancer West Enterprises, Inc. a California corporation,
Walnut Ventures, a California corporation, Jason Manasse, an individual, and Theodore Nicols, an individual, pursuant to which
each of Lancer West Enterprises, Inc. and Walnut Ventures were merged with and into Merger Sub, with Merger Sub as the surviving
corporation, resulting in the Company’s indirect acquisition of CMP Wellness, LLC, a California limited liability company,
which prior to the merger, was owned 100% by Lancer West Enterprises, Inc. and Walnut Ventures. CMP Wellness, LLC is a distributor
of vaporizers, cartridges and accessories.
The acquisition
was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations. The purchase
price payable to Jason Manasse and Theodore Nicols at the closing of the merger in exchange for consummating the merger was comprised
of an aggregate of $1,500,000 in cash, unsecured promissory notes in the aggregate principal amount of approximately $770,820,
having a one-year maturity, and an aggregate of 7,800,000 restricted shares of the Company’s common stock. The purchase price
is subject to customary post-closing adjustments with respect to confirmation of the levels of working capital and cash held by
CMP Wellness, LLC as of the closing. During the one-year period following the closing, Jason Manasse and Theodore Nicols
may become entitled to receive up to an additional approximately $1,905,000 in cash, in the aggregate, and approximately 4,740,960
shares of common stock of the Company, in the aggregate, based on the future performance of CMP Wellness, LLC (See Note 2).
Basis of Presentation
The accompanying unaudited condensed consolidated
financial statements and related notes include the activity of the Company and its wholly owned subsidiaries and have been prepared
in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim
financial information. All intercompany balances and transactions have been eliminated. Accordingly, they do not include all of
the information and notes required by generally accepted accounting principles for annual financial statements. In the
opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation
have been included. Our operating results for the three month period ended November 30, 2017 are not necessarily indicative of
the results that may be expected for the fiscal year ended August 31, 2018, or for any other period. These unaudited condensed
consolidated financial statements and notes should be read in conjunction with the Company’s audited consolidated financial
statements and accompanying notes for the fiscal year ended August 31, 2017. The condensed consolidated balance sheet as of August 31,
2017 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including
notes required by GAAP. There have been no changes to our significant accounting policies described in our Annual Report on Form
10-K for the fiscal year ended August 31, 2017 that have had a material impact on our condensed consolidated financial statements
and related notes.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Use of Estimates
The preparation of financial statements in
conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date
of the financial statements, and the reported amount of revenues and expenses during the reporting period.
Significant estimates relied upon in preparing
these unaudited condensed consolidated financial statements include revenue recognition, accounts receivable reserves, inventory
and related reserves, valuations and purchase price allocations related to business combinations, expected future cash flows used
to evaluate the recoverability of long-lived assets, estimated fair values of long-lived assets used to record impairment charges
related to intangible assets and goodwill, amortization periods, accrued expenses, stock-based compensation, and recoverability
of the Company’s net deferred tax assets and any related valuation allowance.
Although the Company regularly assesses these
estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which
they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be
reasonable under the circumstances. Actual results may differ from management’s estimates if past experience or other assumptions
do not turn out to be substantially accurate.
The Company is subject to a number of risks
similar to those of other companies of similar size and having a focus of serving the cannabis industry, including, the development
stage of certain products, competition, limited number of suppliers, integration of acquisitions, substantial indebtedness, government
regulations, protection of proprietary rights, and dependence on key individuals.
Segments
The Company operates as one operating segment.
Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by
the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance.
Over the past few years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand
its offerings, presence and reach in the cannabis industry. While the Company has offerings in multiple geographic locations for
its products for the cannabis industry, including as a result of the Company's acquisitions, the Company’s business operates
in one operating segment because the majority of the Company's offerings operate similarly, and the Company’s chief
operating decision maker evaluates the Company’s financial information and resources and assesses the performance of these
resources on a consolidated basis. Since the Company operates in one operating segment, all required financial segment information
can be found in the unaudited condensed consolidated financial statements.
Cash and Cash Equivalents
The Company considers cash and cash equivalents
to consist of cash on hand and investments having an original maturity of 90 days or less that are readily convertible into cash.
The Company invests its cash and cash equivalents with financial institutions with highly rated credit and monitors the amount
on deposit at the financial institution. As of November 30, 2017 and August 31, 2017, the Company had $5,549,431 and $916,984 respectively.
Accounts Receivable
Trade
accounts receivable are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term
basis, thus trade receivables do not bear interest. Trade accounts receivables are periodically evaluated for collectability
based on past credit history and their current financial condition. The Company’s allowance for doubtful accounts was $40,478
and $25,000 as of November 30, 2017 and August 31, 2017, respectively.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Inventory
Inventories are stated at the lower of cost or net realizable value using the first-in first out (FIFO) method.
The Company’s inventory consists of finished goods of $3,850,678 and $3,754,171 as of
November
30, 2017
and August 31, 2017, respectively.
Property and Equipment
Property and equipment is recorded at cost
less accumulated depreciation. Depreciation is calculated using the straight-line method over the shorter of estimated useful life
of the asset or the lease term, after the asset is placed in service. The estimated useful lives of the property and equipment
are generally as follows: computer software acquired for internal use, three to seven years; computer equipment, two to three years;
leasehold improvements, three to life of lease; and furniture and equipment, one to 7 years. Gains and losses from the retirement
or disposition of property and equipment are included in operations in the period incurred. Maintenance and repairs are expensed
as incurred.
Fair Value of Financial Instruments
The fair value of certain of our financial
instruments, including cash and cash equivalents, receivables, other current assets, accounts payable, accrued compensation and
employee benefits, other accrued liabilities and notes payable, approximate their carrying amounts because of the short-term maturity
of these instruments.
Concentration of
Risk
The Company’s financial instruments that
are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Collateral
is not required for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable. This allowance
is based upon historical loss patterns, the number of days that billings are past due and an evaluation of the potential risk of
loss associated with delinquent accounts. Receivables are written-off and charged against its recorded allowance when the Company
has exhausted collection efforts without success. The Company’s losses related to collection of trade receivables have consistently
been within management’s expectations. Due to these factors, no additional credit risk beyond amounts provided for collection
losses, which the Company reevaluates on a monthly basis based on specific review of receivable aging and the period that any
receivables are beyond the standard payment terms, is believed by management to be probable in the Company’s accounts receivable.
Although, the Company is directly affected
by the overall financial condition of the cannabis industry, management does not believe significant credit risk exists as of November
30, 2017. The Company generally has not experienced any material losses related to receivables from individual customers or groups
of customers. The Company maintains an allowance for doubtful accounts based on accounts past due according to contractual terms
and historical collection experience. Actual losses when incurred are charged to the allowance.
The Company purchases
products from a small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders
and a possible loss of sales, which would adversely affect results of operations; however, management believes that suitable replacement
suppliers could be obtained in such an event.
Intangible Assets acquired through Business
Combinations
Intangible assets, domain name, trademarks and non-compete agreements
that are deemed to have a definite life are amortized over their estimated useful lives and intangible assets with an indefinite
life are assessed for impairment at least annually. Each period, the Company evaluates the estimated remaining useful life of its
intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Impairment Assessment
The Company evaluates intangible assets and
long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount of such
assets may not be recoverable. This includes but is not limited to significant adverse changes in business climate, market conditions,
or other events that indicate an asset's carrying amount may not be recoverable. Recoverability of these assets is measured by
comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate. If the
undiscounted cash flows used in the test for recoverability are less than the carrying amount of these assets, the carrying amount
of such assets is reduced to fair value. The Company evaluates and tests the recoverability of its goodwill for impairment at least
annually during its fourth quarter of each fiscal year or more often if and when circumstances indicate that goodwill may not be
recoverable. There was no impairment of intangible assets, long-lived assets or goodwill during the three months ended November
30, 2017 and for the fiscal year ended August 31, 2017.
Valuation of Business Combinations and Acquisition
of Intangible Assets
The Company records intangible assets acquired
in business combinations and acquisitions of intangible assets under the purchase method of accounting. The Company accounts for
acquisitions in accordance with FASB ASC Topic 805,
Business Combinations
. Amounts paid for each acquisition are allocated
to the assets acquired and liabilities assumed based on their fair values at the dates of acquisition. The Company then allocates
the purchase price in excess of the fair value of the net tangible assets acquired to identifiable intangible assets, including
purchased intangibles based on detailed valuations that use information and assumptions provided by management. The Company allocates
any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.
The Company uses the income approach, the relief
from royalty method (both a market and income method), and the with and without method to determine the fair values of its purchased
intangible assets. The Company uses the probability-weighted expected return method (an income approach) to determine the appropriate
amount of contingent consideration to include in the purchase price for an acquisition. The Company bases its revenue assumptions
on estimates of relevant market sizes, expected market growth rates, expected industry trends and expected product introductions
by competitors. In arriving at the value. The Company bases the discount rate used to arrive at a present value as of the date
of acquisition on the time value of money and cannabis industry investment risk factors. For the intangible assets acquired, the
Company used risk-adjusted discount rates ranging from 19% to 26% to discount its projected cash flows. The Company believes that
the estimated purchased intangible asset amounts so determined represent the fair value at the date of acquisition and do not exceed
the amount a third party would pay for the projects.
The Company also used the income approach (probably
weighted cash flow), as described above, to determine the estimated fair value of certain identifiable intangibles assets including
domain names and tradenames. Domain names represent established relationships with customers, which provides a ready channel for
the sale of additional products and services. Tradenames represent acquired product names that the Company intends to continue
to utilize. The Company used the with and without method to ascertain the fair value of the non-competition agreement.
Goodwill and Intangible Assets
Goodwill and intangible assets that have indefinite
useful lives are not amortized but are evaluated for impairment annually or whenever events or changes in circumstances indicate
that the carrying value may not be recoverable. The Company records intangible assets at historical cost. The Company amortizes
its intangible assets that have finite lives using either the straight-line method or based on estimated future cash flows to approximate
the pattern in which the economic benefit of the asset will be utilized. Amortization is recorded over the estimated useful lives
ranging from four to six years. The Company reviews intangible assets subject to amortization quarterly to determine if any adverse
conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life.
Conditions that would indicate impairment and trigger a more frequent impairment assessment include, but are not limited to, a
significant adverse change in legal factors or business climate that could affect the value of an asset, or an adverse action or
assessment by a regulator. If the carrying value of an asset exceeds its undiscounted cash flows, the Company will write-down the
carrying value of the intangible asset to its fair value in the period identified. The Company generally calculates fair value
as the present value of estimated future cash flows to be generated by the asset using a risk-adjusted discount rate. If the estimate
of an intangible asset’s remaining useful life is changed, the Company will amortize the remaining carrying value of the
intangible asset prospectively over the revised remaining useful life.
Consistent with prior years, the Company conducted
its annual impairment test of goodwill during the fourth quarter of fiscal 2017. The estimate of fair value requires significant
judgment. Any loss resulting from an impairment test would be reflected in operating income in the Company’s unaudited condensed
consolidated statements of income. The annual impairment testing process is subjective and requires judgment at many points throughout
the analysis. If these estimates or their related assumptions change in the future, the Company may be required to record impairment
charges for these assets not previously recorded.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Business Combinations
The Company uses its best estimates and assumptions
to accurately assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date.
The Company’s estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up
to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets
acquired and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related
valuation allowances are initially established in connection with a business combination as of the acquisition date. The Company
continues to collect information and reevaluates these estimates and assumptions quarterly and records any adjustments to the Company’s
preliminary estimates to goodwill provided that the Company is within the measurement period. Upon the conclusion of the measurement
period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent
adjustments are recorded to the Company’s condensed consolidated statements of operations.
Earnings (Loss) Per Share
The Company computes earnings per share under
Accounting Standards Codification subtopic 260-10, "Earnings per Share" (“ASC 260-10”). Basic net income
(loss) per common share is computed by dividing net loss by the weighted average number of shares of common stock. Diluted
net loss per share is computed using the weighted average number of common and common stock equivalent shares outstanding during
the period.
Basic earnings per share are computed by dividing
net earnings by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share
are computed by dividing net earnings by the sum of (a) the weighted average number of shares of common stock outstanding during
the period and (b) the potentially dilutive securities outstanding during the period. Stock options are potentially dilutive securities;
and the number of dilutive options is computed using the treasury stock method. The effect of the contingent equity consideration
relating to the acquisition of CMP is also factored into the calculation of dilutive securities.
The following table sets forth the calculation
of basic and diluted earnings per share:
|
|
Three months ended
|
|
|
|
November 30,
|
|
|
November 30,
|
|
|
|
2017
|
|
|
2016
|
|
Net income (loss)
|
|
$
|
94,615
|
|
|
$
|
(161,958
|
)
|
Weighted average common shares outstanding for basic EPS
|
|
|
59,194,323
|
|
|
|
48,713,496
|
|
Net effect of dilutive options
|
|
|
1,973,085
|
|
|
|
1,797,803
|
|
Net effect of contingent equity consideration
|
|
|
4,740,960
|
|
|
|
—
|
|
Weighted average common shares outstanding for diluted EPS
|
|
|
65,908,368
|
|
|
|
50,511,299
|
|
Basic earnings (loss) per share
|
|
$
|
0.00
|
|
|
$
|
(0.00
|
)
|
Diluted earnings (loss) per share
|
|
$
|
0.00
|
|
|
$
|
(0.00
|
)
|
Comprehensive Income (loss)
Comprehensive income (loss) is the change
in the Company’s equity (net assets) during each period from transactions and other events and circumstances from non-owner
sources. During the quarters ended November 30, 2017 and 2016, the Company had no elements of comprehensive income or loss.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Revenue Recognition
It is
the Company’s policy that revenues from product sales is recognized in accordance with ASC 605 "Revenue Recognition".
Four basic criteria must be met before revenue can be recognized; (1) persuasive evidence of an arrangement exists; (2) delivery
has occurred; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured. Determination
of criteria (3) and (4) are based on management’s judgments regarding fixed nature in selling prices of the products delivered
and the collectability of those amounts. The Company has not implemented any specific rebate programs. Provisions for discounts
to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related sales are
recorded.
During the three month period ended November 30, 2017 and 2016, we had no provisions for sales discounts of $0
and $19,457, respectively.
The Company has not established a formal customer incentive program,
but considers and accommodates discounts to certain customers on a case by case basis, including by way of example, for volume
shipping or for certain new customers with orders over a specific discretionary dollar threshold. The Company classifies the reimbursement
by customers of shipping and handling costs as revenue and the associated cost as cost of revenue.
As of November 30, 2017 and, 2016, the
Company had a refund allowance of $0 and $0, respectively.
Consistent with ASC
605-15-25-1, the Company considers factors such as historical return of products, estimated remaining shelf life, price
changes from competitors, and introductions of competing products in establishing a refund allowance. The Company recognizes
revenues as risk and title to products transfers to the customer (which generally occurs at the time shipment is made), the
sales price is fixed or determinable, and collectability is reasonably assured. The Company defers any revenue
for which the product was not delivered or is subject to refund until such time that the Company and the customer jointly
determine that the product has been delivered or no refund will be required.
Warranty Costs
The
Company has not had any historical warranty related expenditures from the sales of its products, which if incurred would result
in the return of any defective products by customers
.
Share-based Compensation
The Company account for its stock based award
in accordance with Accounting Standards Codification subtopic 718-10, "Compensation", which requires fair value measurement
and recognition of compensation expense for all share-based payment awards made to employees and directors, including restricted
stock awards. The Company estimates the fair value of stock using the stock price on the date of the approval of the award.
The fair value is then expensed over the requisite service periods of the awards, which is generally the performance period
and the related amount is recognized in the consolidated statements of operations.
Advertising
The Company
conducts advertising for the promotion of its products and services. In accordance with ASC Topic 720-35-25, advertising costs
are charged to operations when incurred.
Income Taxes
The Company accounts for income taxes in accordance with accounting
guidance now codified as FASB ASC 740, "Income Taxes," which requires that the Company recognize deferred tax liabilities
and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities,
using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results
from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely
than not that some or all deferred tax assets will not be realized.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The Company applies the provisions of ASC 740,
"Accounting for Uncertainty in Income Taxes". The ASC prescribes a recognition threshold and measurement attribute for
the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The
ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and
transition. The Company utilizes a two-step approach to recognizing and measuring uncertain tax positions (tax contingencies).
The first step evaluates the tax position for recognition by determining if the weight of available evidence indicates it is more
likely than not that we will sustain the position on audit, including resolution of related appeals or litigation processes. The
second step measures the tax benefit as the largest amount more than 50% likely of being realized upon ultimate settlement. The
Company did not identify any material uncertain tax positions on returns that have been filed or that will be filed. The
Company did not recognize any interest or penalties for unrecognized tax benefits during the three month ended November 30, 2017
and the fiscal year ended August 31, 2017, nor were any interest or penalties accrued as of November 30, 2017 and August 31, 2016.
Fair Value of Financial
Instruments
The
Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation
framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements
and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures
are required for items measured at fair value
.
The
Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value
on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the
fair value hierarchy. The three levels are as follows
:
Level 1 -
Inputs
are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at
the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1
.
Level 2 -
Inputs
include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities
in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest
rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation
or other means (market corroborated inputs)
.
Level 3 -
Unobservable
inputs that reflect management’s assumptions about the assumptions that market participants would use in pricing the asset
or liability
.
Application of
Valuation Hierarchy
Financial
instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to
the fair value measurement. The following is a description of the valuation methodology used to measure fair value, as well as
the general classification of such instruments pursuant to the valuation hierarchy
.
The
Company has a contingent consideration liability of $1,820,000, which consists of contingent cash consideration of $1,820,000
resulting from the acquisition of CMP (Note 2). The contingent consideration liability is calculated based on the weighted average
probability of meeting certain milestones. This liability is remeasured at each reporting period. The Company had no other financial
assets or liabilities that are measured at fair value on a recurring basis as of November 30, 2017
.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The following table summarizes, for assets
or liabilities measured at fair value, the respective fair value and the classification by level of input within the fair value
hierarchy:
|
|
|
|
|
Fair Value Measurement at
Reporting Date Using
|
|
Description
|
|
November 30, 2017
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Contingent consideration liability
|
|
$
|
1,820,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,820,000
|
|
The Company classifies its contingent
consideration liability within Level 3 as the valuation inputs are based on quoted market prices and market observable data.
During the three months ended November 30, 2017, the Company did not recognize any change in the fair value of its contingent
consideration liability of $1,820,000.
Recently Issued
Accounting Pronouncements
In September 2017, the FASB issued Accounting
Standards Update (ASU) No. 2017-13,
“Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606),
Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017
EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.”
The amendments in ASU No. 2017-13
amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. The
Company may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same
as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.
In January 2017, the FASB issued Accounting
Standards Update No. 2017-04,
Simplifying the Test for Goodwill Impairment
("ASU 2017-04"). ASU 2017-04
simplifies the accounting for goodwill impairment by removing Step 2 of the goodwill impairment test, which requires a hypothetical
purchase price allocation. ASU 2017-04 is effective for annual or interim goodwill impairment tests in fiscal years beginning after
December 15, 2019, and should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment
tests performed on testing dates after January 1, 2017. The Company does not anticipate the adoption of ASU 2017-04 will have a
material impact on its consolidated financial statements.
In January 2017, the FASB issued Accounting
Standards Update No. 2017-01,
Business Combinations (Topic 805): Clarifying the Definition of a Business
(ASU
2017-01), which revises the definition of a business and provides new guidance in evaluating when a set of transferred assets and
activities is a business. This guidance will be effective for the Company in the first fiscal quarter of 2018 on a prospective
basis, and early adoption is permitted. The Company does not expect the standard to have a material impact on our consolidated
financial statements.
In August, 2016, the FASB issued Accounting
Standards Update No. 2016-15,
Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues
Task Force)
(“ASU 2016-15”). The amendments in ASU 2016-15 address eight specific cash flow issues and apply
to all entities that are required to present a statement of cash flows under ASC Topic 230,
Statement of Cash Flows
.
The amendments in ASU 2016-15 are effective for public business entities for fiscal years beginning after December 15, 2017, and
interim periods within those fiscal years. Early adoption is permitted, including adoption during an interim period. The Company
has not yet completed the analysis of how adopting this guidance will affect its consolidated financial statements.
In May 2016, accounting guidance was issued
to clarify the not yet effective revenue recognition guidance issued in May 2014. This additional guidance does not change the
core principle of the revenue recognition guidance issued in May 2014, rather, it provides clarification of accounting for collections
of sales taxes as well as recognition of revenue (i) associated with contract modifications, (ii) for noncash consideration,
and (iii) based on the collectability of the consideration from the customer. The guidance also specifies when a contract should
be considered “completed” for purposes of applying the transition guidance. The effective date and transition requirements
for this guidance are the same as the effective date and transition requirements for the guidance previously issued in 2014, which
is effective for interim and annual periods beginning on or after December 15, 2017. The new standard also permits two methods
of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the
cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective
method). The Company’s management currently anticipates adopting the standard using the modified retrospective method. While
management is still in the process of completing the analysis on the impact this guidance will have on the Company’s consolidated
financial statements, related disclosures, and its internal controls over financial reporting. The Company has not yet determined
whether the impact that this new guidance will be material to its consolidated financial statements.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
In March 2016, the FASB issued ASU 2016-09,
Compensation—Stock
Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting
. The amendments in this update change existing
guidance related to accounting for employee share-based payments affecting the income tax consequences of awards, classification
of awards as equity or liabilities, and classification on the statement of cash flows. ASU 2016-09 is effective for annual reporting
periods beginning after December 15, 2016, including interim periods within those annual periods, with early adoption permitted.
The Company is currently evaluating the potential impact of the adoption of this standard
In February 2016, the FASB issued ASU 2016-02,
Leases
(Topic 842)
. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset
and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. Leases will be classified
as either finance or operating, with classification affecting the pattern of expense recognition in the consolidated income statement.
ASU 2016-02 is effective for annual periods beginning after December 15, 2018, including interim periods within those annual periods,
with early adoption permitted. A modified retrospective transition approach is required for lessees for capital and operating leases
existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with
certain practical expedients available. The Company is currently evaluating the potential impact of the adoption of this standard.
In January 2016, the FASB issued ASU 2016-01,
Recognition
and Measurement of Financial Assets and Financial Liabilities
. The amendments in this update revise the accounting related
to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for
financial liabilities measured at fair value. The amendments are effective for annual reporting periods after December 15, 2017,
including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the potential
impact of the adoption of this standard.
Other
Accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected
to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements
that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or
disclosures.
NOTE 2 – ACQUISITION OF CMP WELLNESS,
LLC
On May
1, 2017 (“Merger Date”), the Company and KBCMP, Inc., a Delaware corporation and newly formed wholly-owned subsidiary
of the Company (“Merger Sub”), entered into an Agreement of Merger (the “Merger Agreement”) with Lancer
West Enterprises, Inc. a California corporation and Walnut Ventures, a California corporation, pursuant to which each of Lancer
West Enterprises, Inc. and Walnut Ventures were merged with and into Merger Sub, with Merger Sub as the surviving corporation,
resulting in the Company’s indirect acquisition of CMP Wellness, LLC (“CMP”), a California limited liability
company, which prior to the merger, was owned 100% by Lancer West Enterprises, Inc. and Walnut Ventures. Membership interest in
CMP was the sole and only asset of Lancer West Enterprises, Inc. and Walnut Ventures. As a result, CMP became a wholly-owned subsidiary
of the Company. CMP is a distributor of vaporizers, cartridges and accessories.
The Company’s Directors believed
the acquisition of CMP and the product offerings of CMP leveraged the Company’s existing product development program and
provided the Company with the possibility of generating near term revenue and operating cash flow, as well as establishing a commercial
platform whereby other cannabis industry-support products may be accessed in the future. Going forward, the existing product offering
and other product licensing opportunities, will be the basis of the Company's long-term product portfolio.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The acquisition
consideration consisted of a cash payment of $1,500,000, unsecured promissory notes in the aggregate principal amount of approximately
$770,820, having a one-year maturity, and an aggregate of 7,800,000 restricted shares of the Company’s common stock (equal
to13.0% of the Company’s common stock outstanding as of November 30, 2017). During the one-year period following the closing,
the two sellers of CMP may become entitled to receive up to an additional $1,905,000 in cash, in the aggregate, and 4,740,960 shares
of common stock of the Company, in the aggregate, based on the gross profit generated by CMP product line for the period from May
1, 2017 to April 30, 2018. Per the terms of the Merger Agreement, post-closing adjustments to CMP’s working capital is directly
offset to the unsecured promissory notes payable. Management has estimated that the post-closing working capital adjustments amounted
to $104,032, which management estimates will result in a decrease of the unsecured promissory notes payable from $770,820 to $666,788.
In accordance with ASC 805, management has evaluated the estimated fair value of the contingent consideration based a probability-weighted
assessment of the occurrence of CMP reaching certain gross profit earnout targets. The Company initially recorded a contingent
liability for the contingent cash consideration of $1,735,375 $1,905,000 and recorded contingent equity consideration of $10,763,760.
Based on information obtained during the fourth fiscal quarter, the Company revised its estimate of the contingent cash consideration
from $1,735,375 to $1,905,000, and its estimate of the contingent equity consideration from $10,763,760 to $11,852,400. The fair
value of the contingent equity consideration is recorded in additional paid in capital.
CMP’s
assets acquired and liabilities assumed are recorded at their acquisition-date fair values.
As
part of the purchase price allocation, all intangible assets that were a part of the acquisition were identified and valued. It
was determined that only non-competition agreements and trade name had separately identifiable values. Trade name represents the
CMP product names that the Company intends to continue to use. The deferred income tax liability relates to the tax effect of acquired
identifiable intangible assets as such amounts are not deductible for tax purposes.
For
the acquisition discussed above, goodwill represents the excess of the purchase price over the net identifiable tangible and intangible
assets acquired. The Company determined that the acquisition of CMP resulted in the recognition of goodwill primarily because of
synergies unique to the Company and the strength of its acquired workforce.
The results of operations of CMP were consolidated
beginning on the date of the merger.
Acquisition-related transaction costs are
not included as a component of consideration transferred, but are accounted for as an expense in the period in which the costs
are incurred. Any excess of the acquisition consideration over the fair value of tangible and intangible assets acquired and liabilities
assumed is allocated to goodwill.
The amount of contingent consideration was recorded at its estimated fair value as
of the acquisition date. The subsequent accounting for contingent consideration depends on whether the contingent consideration
is classified as a liability or equity. The portion of contingent consideration classified as equity is not remeasured in subsequent
accounting periods. However, contingent consideration classified as a liability is remeasured to its fair value at the end of each
reporting period and the change in fair value is reflected in income or expense during that period. Any changes within the measurement
period resulting from facts and circumstances that existed as of the acquisition date may result in retrospective adjustments to
the provisional amounts recorded at the acquisition date.
The equity consideration received by CMP members was calculated
based on the negotiated price per share of common stock of the Company of $2.50, which approximated the quoted market price on
the acquisition date. The contingent equity consideration (number of common shares) was also calculated based on the negotiated
price per share of common stock of the Company of $2.50, which approximated the quoted market price. The total preliminary acquisition
consideration used in preparing the consolidated financial statements is as follows:
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Acquisition
Consideration:
|
|
May 1, 2017
|
|
|
Measurement
|
|
|
November 30,
|
|
|
|
(As initially
reported)
|
|
|
Period
Adjustments (1)
|
|
|
2017
(As adjusted)
|
|
Cash
|
|
$
|
1,500,000
|
|
|
$
|
—
|
|
|
$
|
1,500,000
|
|
Fair value of common shares issued to CMP members
|
|
|
19,500,000
|
|
|
|
—
|
|
|
|
19,500,000
|
|
Promissory notes
|
|
|
660,216
|
|
|
|
6,572
|
|
|
|
333,393
|
|
Estimated fair value contingent cash consideration
|
|
|
1,735,375
|
|
|
|
169,625
|
|
|
|
1,905,000
|
|
Estimated fair value contingent equity consideration
|
|
|
10,763,760
|
|
|
|
1,088,640
|
|
|
|
11,852,400
|
|
Total estimated acquisition consideration
|
|
$
|
34,159,351
|
|
|
$
|
1,264,837
|
|
|
$
|
35,090,793
|
|
|
(1)
|
As
of August 31, 2017, the Company revised its estimate of the contingent cash consideration from $1,735,375 to $1,905,000, and the
Company revised its estimate of the contingent equity consideration from $10,763,760 to $11,852,400, to reflect the increased
probability of the sellers of CMP reaching the maximum earnouts available. An additional post-closing adjustment of $6,572 was
recorded, which resulted in an increase of the promissory notes from $660,216 to $666,788. The balance of the note payable at
November 30, 2017 reflects principal payments of $333,395 made to the sellers of CMP.
|
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 3 – CONCENTRATIONS OF RISK
Supplier Concentrations
The Company purchases inventory from various suppliers and manufacturers. For the three months ended
November
30, 2017 and 2016, two vendors, Transpring and Shenzhen Buddy Technology Co. Ltd., accounted for approximately 30% and 13%, respectively,
of total inventory purchases.
Customer Concentrations
During the three months ended November
30, 2017 there was one customer which represented over 10% of the Company’s revenues there were no such customers for the
same period ended November 30, 2016. As of November 30, 2017, there were two customers who represented 26% of accounts receivable.
As of November 30, 2017, there was one customer that accounted for over 10% of accounts receivable.
NOTE 4 – RELATED-PARTY TRANSACTIONS
The Company leases
its California and Colorado facilities from related parties. During the three months ended November 30, 2017 and 2016, the Company
made rent payments of $53,660 and $50,700, respectively, to these related parties.
NOTE 5 – PROPERTY AND EQUIPMENT
The major classes of fixed assets consist
of the following as of November 30, 2017 and August 31, 2017:
|
|
November 30,
|
|
|
August 31,
|
|
|
|
2017
|
|
|
2017
|
|
Machinery and equipment
|
|
$
|
887,203
|
|
|
$
|
886,608
|
|
Vehicles
|
|
|
144,845
|
|
|
|
144,845
|
|
Office Equipment
|
|
|
130,085
|
|
|
|
118,387
|
|
Leasehold improvements
|
|
|
107,832
|
|
|
|
71,545
|
|
|
|
|
1,269,965
|
|
|
|
1,221,385
|
|
Accumulated Depreciation
|
|
|
(345,093
|
)
|
|
|
(289,622
|
)
|
|
|
$
|
924,872
|
|
|
$
|
931,763
|
|
Depreciation expense was $55,472 and $29,510,
for the three months ended November 2017 and 2016, respectively. Of the $55,472 of depreciation expense, $13,696 is included in
depreciation and amortization expense and $41,776 is included in cost of goods sold on the consolidated statements of operations.
NOTE 6 – INTANGIBLE ASSETS
On May 3, 2017, pursuant to
an Asset Purchase Agreement between the Company and RUB Acquisition, LLC (“Seller”), the Company acquired the domain
name and inventory for $150,000 in cash and 200,000 shares of restricted common stock having a fair value of $466,000. During the
one-year period following the closing, the Seller may become entitled to receive up to an additional $100,000 in cash and 400,000
shares of common stock of the Company if certain contingent milestones are achieved. The Company accounted for the contingent
consideration based upon a probability-weighted assessment of the occurrence of triggering events outlined in the asset purchase
agreement. The Company initially recorded a preliminary contingent liability for the contingent cash consideration of $50,000 and
recorded contingent equity consideration of $466,000. As of August 31, 2017, management determined that the probability of the
Seller receiving the contingent earnout payments was remote. As a result and pursuant to guidance in ASC Topic 360-10-30-1 and
Topic 450-20-25-2, the Company reduced the basis of the intangible asset by $516,000 to reflect these change of events. The fair
value of the equity consideration issued at closing and the fair value of the contingent equity consideration was based on the
closing price of the Company’s stock on May 3, 2017, which was $2.33.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The total acquisition consideration used in preparing the consolidated
financial statements is as follows:
Asset Acquisition Consideration:
|
|
|
|
Cash
|
|
$
|
150,000
|
|
Fair value of common shares issued to seller
|
|
|
466,000
|
|
Total estimated acquisition consideration
|
|
$
|
616,000
|
|
The following table summarizes the allocation of the fair values
of the assets acquired:
Inventory
|
|
$
|
26,716
|
|
Finite-lived intangible assets:
|
|
|
|
|
Domain name
|
|
|
589,284
|
|
Net assets acquired
|
|
|
616,000
|
|
Total fair value of consideration
|
|
$
|
616,000
|
|
As a
result of the acquisition of CMP Wellness, LLC, on May 1, 2017, the Company identified an intangible asset of $2,600,000 relating
to the CMP trade name acquired and $800,000 relating to non-compete agreement.
Intangible
assets consist of the following:
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
As of November 30, 2017
|
|
|
As of November 30, 2016
|
|
|
|
|
|
Estimated
|
|
Gross
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
|
|
Useful
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
Accumulated
|
|
Acquisition
|
|
Description
|
|
Life
|
|
Value
|
|
|
Amortization
|
|
|
Value
|
|
|
Amortization
|
|
Roll-Uh-Bowl
|
|
Domain name
|
|
5 years
|
|
$
|
589,284
|
|
|
$
|
(77,350
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMP Wellness, LLC
|
|
Trade name
|
|
6 years
|
|
|
2,600,000
|
|
|
|
(252,777
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
Non-compete agreement
|
|
4 years
|
|
|
800,000
|
|
|
|
(116,667
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
$
|
3,989,284
|
|
|
$
|
(446,794
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
The Company operates as one reporting segment. The Company determined that the web domain has an estimated
useful life of five (5) years. The Company determined that the trade name has an estimated useful life of six (6) years and the
non-compete has an estimated useful life of four (4) years. Amortization expense related to domain name, trade name and non-competition
agreement is classified as a component of amortization of acquired intangible assets in the accompanying consolidated statement
of operations. Accordingly, amortization expense of $188,118 was recorded for the three months ended November 30, 2017.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 7 – ACCRUED EXPENSES AND OTHER
CURRENT LIABILITIES
Accrued expenses and other current liabilities
consist of the following:
|
|
November 30,
|
|
|
August 31,
|
|
|
|
2017
|
|
|
2017
|
|
Customer deposits
|
|
$
|
710,063
|
|
|
$
|
342,909
|
|
Accrued compensation
|
|
|
189,748
|
|
|
|
245,975
|
|
Income tax payable
|
|
|
273,497
|
|
|
|
219,082
|
|
Credit card liabilities
|
|
|
51,854
|
|
|
|
142,157
|
|
Deferred rent
|
|
|
25,301
|
|
|
|
25,881
|
|
Sales tax payable
|
|
|
13,591
|
|
|
|
17,182
|
|
|
|
$
|
1,264,054
|
|
|
$
|
993,186
|
|
NOTE 8 – NOTES PAYABLE
As partial
consideration for the acquisition of CMP, the Company issued the sellers unsecured promissory notes totaling $770,820. Management
has estimated that the post-closing working capital adjustments amounted to $104,032, which resulted in a decrease of the unsecured
promissory notes payable from $770,820 to $666,788. The promissory notes mature on May 1, 2018 and bear interest at an annual rate
of 1.15%. The notes and accrued and unpaid interest are payable in quarterly installments beginning August 1, 2017. As of November
30, 2017, management has accrued for $1,438 of interest on the promissory notes, which is included in accrued expenses and other
current liabilities. The principal balance of $
333,394
is recognized in the current
portion of notes payable in the consolidated balance sheet as of
November 30
, 2017.
Principal payments of $333,394 were made during the quarter ended November 30, 2017.
Automobile Contracts Payable
The Company has entered into purchase contracts for its vehicles.
The loans are secured by the vehicles and bear interest at an average interest rate of approximately 6% per annum. Future
principal payments on these automobile contracts payable is summarized in the table below:
|
|
Principal
|
|
Year ended August 31,
|
|
Due
|
|
2018
|
|
$
|
20,483
|
|
2019
|
|
|
17,453
|
|
2020
|
|
|
10,679
|
|
2021
|
|
|
3,063
|
|
|
|
$
|
51,678
|
|
NOTE 9 – LOAN AGREEMENT
On November 16, 2017, we and KIM as borrowers, and all of our other subsidiaries, as credit parties, entered
into a Loan and Security Agreement (the “Loan Agreement”) with Gerber Finance Inc., as lender (“Gerber”),
effective as of November 6, 2017. The Loan Agreement provides a secured revolving credit facility (the “Revolving Line”)
in an aggregate principal amount of up to $2.0 million at any time outstanding, of which $1,502,418 including accrued interest
was outstanding on November 30
th
, 2017. Under the terms of the Loan Agreement, the principal amount of loans, plus the
face amount of any outstanding letters of credit, at any time outstanding cannot exceed up to 85% of our eligible receivables minus
reserves. Under the terms of the Loan Agreement, we may also request letters of credit from Gerber. The proceeds of the loans under
the Loan Agreement will be used for working capital and general corporate purposes. The Revolving Line has a maturity date of November
6, 2019. Borrowings under the Revolving Line accrues interest at a rate based on the prime rate as customarily defined, plus a
margin of 3.0%.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 10 – STOCKHOLDERS' EQUITY
Preferred Stock
The authorized preferred stock is 10,000,000
shares with a par value of $0.001. As of November 30, 2017 and August 31, 2017, the Company has no shares of preferred stock issued
or outstanding.
Common Stock
The authorized common stock is 265,000,000 shares with a par value of $0.0
01.
As of November 30, 2017 and August 31, 2017, 60,006,178 and 58,607,066 shares were issued and outstanding, respectively.
During the three months ended November 30, 2017, the Company sold 1,363,674 shares of its common stock
to investors in exchange for cash of $2,045,505. For the same period ended November 30, 2017 the Company collected $2,564,050 of
cash in advance of issuing the related 1,709,366 shares in the subsequent period. This amount is reflected as stock payable in
the Company’s financial statements at November 30, 2017.
Share-based Compensation
The Company recorded stock compensation expense
of $381,743 and $115,244 for the three month periods ended November 30, 2017 and 2016, respectively, in connection with the issuance
of shares of common stock and options to purchase common stock.
During the three month period ended November 30, 2017, the Company issued 27,231 shares of common stock
to consultants in exchange for $20,000 of services rendered and $34,077 of prepaid services, for a total of $54,077. The $34,077
of prepaid services is included in prepaid expenses on the condensed consolidated balance sheet of which $14,602 has been amortized
as of November 30, 2017.
Stock Options
The Company’s 2016 Stock Incentive Plan
(the Plan) was adopted on February 9, 2016. The Plan permits the grant of share options and shares to its employees and directors
for up to 5,000,000 shares of common stock. The Company believes that such awards better align the interests of its employees with
those of its shareholders. Option awards are generally granted with an exercise price equal to the market price of the Company's
stock at the date of grant; those option awards generally vest based on three years of continuous service and have 10-year contractual
terms.
The Company
estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon
several variables such as the expected option term, expected volatility of our stock price over the expected option term, expected
risk-free interest rate over the expected option term, expected dividend yield rate over the expected option term, and an estimate
of expected forfeiture rates. The Company believes this valuation methodology is appropriate for estimating the fair value of stock
options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus
may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes
compensation on a straight-line basis over the requisite service period for each award. The following table summarizes the assumptions
the Company utilized to record compensation expense for stock options granted during the three months ended
November 30,
2017
and 2016:
|
|
November 30,
|
|
|
November 30,
|
|
|
|
2017
|
|
|
2016
|
|
Expected term (years)
|
|
|
1-4
|
|
|
|
1-4
|
|
Expected volatility
|
|
|
60
|
%
|
|
|
60
|
%
|
Weighted-average volatility
|
|
|
60
|
%
|
|
|
60
|
%
|
Risk-free interest rate
|
|
|
1.14%-1.97
|
%
|
|
|
0.85%-1.57
|
%
|
Dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Expected forfeiture rate
|
|
|
33
|
%
|
|
|
33
|
%
|
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The expected
life is computed using the simplified method, which is the average of the vesting term and the contractual term. The expected volatility
is based on management's analysis of historical volatility for comparable companies. The risk-free interest rate is based on the
U.S. Treasury yields with terms equivalent to the expected term of the related option at the time of the grant. While the Company
believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a
higher expected volatility was used, or if the expected dividend yield increased.
During
the three months ended November 30, 2017 and 2016, the Company issued 960,500 and 431,500 stock options, respectively, pursuant
to the Company’s 2016 Stock Incentive Plan. A summary of the Company’s stock option activity during the three month
period ended November 30, 2017 is presented below:
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
No. of
|
|
|
Exercise
|
|
|
Contractual
|
|
|
Intrinsic
|
|
|
|
Options
|
|
|
Price
|
|
|
Term
|
|
|
Value
|
|
Balance Outstanding, August 31, 2017
|
|
|
5,275,500
|
|
|
$
|
1.73
|
|
|
|
8.0 years
|
|
|
$
|
917,610
|
|
Granted
|
|
|
960,500
|
|
|
$
|
2.25
|
|
|
|
9.9 years
|
|
|
|
—
|
|
Exercised
|
|
|
10,000
|
|
|
$
|
1.00
|
|
|
|
—
|
|
|
|
—
|
|
Forfeited
|
|
|
37,500
|
|
|
$
|
1.83
|
|
|
|
—
|
|
|
|
—
|
|
Balance Outstanding, November 30, 2017
|
|
|
6,188,500
|
|
|
$
|
1.81
|
|
|
|
8.8 years
|
|
|
|
6,389,845
|
|
Exercisable, November 30, 2017
|
|
|
1,999,000
|
|
|
$
|
0.94
|
|
|
|
8.2 years
|
|
|
|
4,242,215
|
|
The weighted-average grant-date fair value of options granted during the three months ended
November
30, 2017 and 2016
, was $2.25 and $1.83, respectively.
The weighted-average grant-date fair value of options forfeited during the three months ended
November
30, 2017
was $1.83.
During the three months ended November
30, 2017, the Company issued 4,709 shares of common stock pursuant to cashless exercises of 10,000 stock options.
A summary of the status of the Company’s
non-vested options as of August 31, 2017, and changes during the three month period ended November 30, 2017, is presented below:
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
Average
|
|
|
|
No. of
|
|
|
Grant-Date
|
|
|
|
Options
|
|
|
Fair Value
|
|
Nonvested at August 31, 2017
|
|
|
3,679,972
|
|
|
$
|
1,878,144
|
|
Granted
|
|
|
960,500
|
|
|
|
2,158,955
|
|
Exercised
|
|
|
(10,000
|
)
|
|
|
8,003
|
|
Vested
|
|
|
(403,472
|
)
|
|
|
(92,902
|
)
|
Forfeited
|
|
|
(37,500
|
)
|
|
|
(69,300
|
)
|
Nonvested at November 30, 2017
|
|
|
4,189,500
|
|
|
$
|
4,260,701
|
|
As of November 30, 2017, there was $3,703,25 of total unrecognized compensation cost related to non-vested
share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period
of 1.9 years. The total fair value of shares vested during the three month period November 30, 2017 is $214,031. This amount
is included in stock compensation expense on the consolidated statements of operations.
KUSH BOTTLES, INC. AND SUBSIDIARIES
NOTES TO CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
NOTE 11 – COMMITMENTS AND CONTINGENCIES
Lease
The
Company’s corporate head-quarters and primary distribution center is located in Santa Ana, California. In July 2017, the
Company entered into a facility lease in Garden Grove, California. The Garden Grove facility lease expires on August 1, 2022 and
requires escalating monthly payments that range between $24,480 and $28,379. As part of the acquisition of CMP on May 1, 2017,
the Company assumed the lease for CMP’s facility located in Lawndale, California. The lease expires in January 2019, and
requires escalating monthly payments that range between $4,031 and $4,143. On April 1, 2016, the Company entered into a sublease
agreement for a facility located in Woodinville, Washington. The lease commenced on July 15, 2016 and expires on January 31, 2020,
and requires escalating monthly payments that range between $14,985 and $16,022. Effective April 10, 2015, the Company assumed
the facility lease in Denver, Colorado, which is the headquarters of operations for its wholly-owned subsidiary, Dank. On September
1, 2016, the Colorado facility lease was amended to include additional office space. The lease runs through March 31, 2020 and
requires escalating monthly payments, ranging between $4,800 and $7,300. During the three months ended
November
30, 2017 and 2016, the Company recognized $160,093 and $94,418, respectively, of rental expense, related to its office, retail
and warehouse space. The increase is the result of the addition of the CMP Wellness facility as well as expenses related to the
Company’s new headquarters in Garden Grove, CA.
Minimum future commitments under non-cancelable
operating leases and other obligations were as follows:
Year ended August 31,
|
|
|
2018
|
|
|
453,619
|
|
2019
|
|
|
601,102
|
|
2020
|
|
|
444,420
|
|
2021
|
|
|
322,604
|
|
2022
|
|
|
332,278
|
|
|
|
$
|
2,154,023
|
|
CMP Wellness
During the one-year period following the acquisition of CMP (see
Note 2) the two sellers of the business may become entitled to receive up to an additional $1,820,000 in cash and 4,740,960 shares
of common stock of the Company. The liability is based on the gross profit generated by CMP product line for the period from May
1, 2017 to April 30, 2018 as outlined in the acquisition agreement.
Other Commitments
In the ordinary course of business, the Company may enter into contractual
purchase obligations and other agreements that are legally binding and specify certain minimum payment terms. The Company had no
such agreements as of
November 30, 2017
.
Litigation
The Company may be subject to legal proceedings
and claims which arise in the ordinary course of its business. Although occasional adverse decisions or settlements may occur,
the Company believes that the final disposition of such matters should not have a material adverse effect on its financial position,
results of operations or liquidity. The Company had no pending legal proceedings or claims as of
November
30, 2017
.
NOTE 12 – SUBSEQUENT EVENTS
Subsequent to November
30, 2017 and through January 12, 2018, the Company issued 67,500 shares related to options exercised for $78,300 in cash.